Loading
Life sciences · Journal article
BMC Cancer · September 25, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
To investigate the association between emotional distress (ED) and pathological response to neoadjuvant immune checkpoint inhibitor (ICI)-based therapy in patients with locally advanced gastric cancer (GC). In this retrospective cohort study (April 2022–December 2024), 129 advanced GC patients receiving neoadjuvant anti-PD-1 therapy were included from two Chinese hospitals. ED was assessed using validated scales (PHQ-9 and GAD-7). ED was defined as a PHQ-9 score ≥ 5 or a GAD-7 score ≥ 5. Outcomes included pathological response (assessed by CAP-TRG) and its correlation with perineural invasion (PNI). Statistical analyses comprised chi-square tests for categorical comparisons and logistic regression to identify independent factors associated with treatment response. Among 129 patients, 38.0% (49/129) exhibited ED. ED patients showed significantly lower immunotherapy response rates than non-ED patients (36.7% vs. 81.3%; P < 0.001). Multivariate logistic regression confirmed ED as an independent negative predictor of response (adjusted OR = 0.252, 95% CI: 0.076–0.809, P = 0.021). ED correlated with higher PNI prevalence (77.8% vs. 26.5%; P < 0.001). Furthermore, within the PD-L1 CPS ≥ 5 subgroup, non-ED patients maintained superior treatment response compared to ED patients. ED is associated with poorer pathological response to neoadjuvant ICI-based therapy in locally advanced GC, potentially through its correlation with PNI. These findings suggest that ED is a potential host-related factor associated with ICI response and highlight the need for psychological support in this population. Prospective studies are warranted to validate the underlying mechanisms and clinical utility.